Nigel Paneth, MD, MPH
Professor of Epidemiology and Pediatrics
College of Human Medicine, Michigan State University
At the end of the activity (presentation), the participants will be better able to:
1. Appreciate the prevalence and burden of cerebral palsy in the U.S.
2. Gain an understanding of the major risks of cerebral palsy.
3. Learn about the use of the transcriptome (mRNA expression) in understanding patho-physiologic pathways that can lead to neurodevelopmental disorders.
4. Understand how archived newborn blood spots, leftover from newborn screening, can be used to provide clues to the causes of cerebral palsy and perhaps other perinatal conditions.